ST14
Basic information
Region (hg38): 11:130159782-130210362
Previous symbols: [ "PRSS14" ]
Links
Phenotypes
GenCC
Source:
- autosomal recessive congenital ichthyosis 11 (Strong), mode of inheritance: AR
- autosomal recessive congenital ichthyosis 11 (Strong), mode of inheritance: AR
- autosomal recessive congenital ichthyosis 11 (Strong), mode of inheritance: AR
- autosomal recessive congenital ichthyosis 11 (Strong), mode of inheritance: AR
- autosomal recessive congenital ichthyosis 11 (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ichthyosis, congenital, autosomal recessive 11 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic | 17273967; 18445049; 18843291 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (108 variants)
- Inborn_genetic_diseases (103 variants)
- ST14-related_disorder (17 variants)
- Autosomal_recessive_congenital_ichthyosis_11 (8 variants)
- High_myopia (1 variants)
- Ichthyosis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ST14 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000021978.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 35 | 13 | 48 | |||
missense | 105 | 17 | 10 | 134 | ||
nonsense | 2 | |||||
start loss | 1 | 1 | ||||
frameshift | 5 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 7 | 7 | 105 | 52 | 23 |
Highest pathogenic variant AF is 0.0000185888
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ST14 | protein_coding | protein_coding | ENST00000278742 | 19 | 50815 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.560 | 0.440 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.25 | 457 | 539 | 0.848 | 0.0000385 | 5582 |
Missense in Polyphen | 121 | 202.74 | 0.59682 | 2114 | ||
Synonymous | 0.378 | 237 | 245 | 0.969 | 0.0000203 | 1646 |
Loss of Function | 4.71 | 9 | 41.9 | 0.215 | 0.00000205 | 481 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000709 | 0.0000703 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing. {ECO:0000269|PubMed:18843291}.;
- Disease
- DISEASE: Ichthyosis, congenital, autosomal recessive 11 (ARCI11) [MIM:602400]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:17273967, ECO:0000269|PubMed:18843291}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- MicroRNAs in cancer - Homo sapiens (human);Keratinization;Developmental Biology;Formation of the cornified envelope
(Consensus)
Recessive Scores
- pRec
- 0.336
Intolerance Scores
- loftool
- 0.0733
- rvis_EVS
- -0.35
- rvis_percentile_EVS
- 29.59
Haploinsufficiency Scores
- pHI
- 0.439
- hipred
- Y
- hipred_score
- 0.678
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.800
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- St14
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; immune system phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- neural tube closure;proteolysis;keratinocyte differentiation;epithelial cell morphogenesis involved in placental branching;cornification
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane;basolateral plasma membrane;extrinsic component of plasma membrane
- Molecular function
- endopeptidase activity;serine-type endopeptidase activity;serine-type peptidase activity